The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma

Histopathology

Volumn 65, Issue 1, 2014, Pages 35-44

  Kao, Chia Sui ^a   Badve, Sunil S ^a   Ulbright, Thomas M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer testis antigens; Germ cell tumour; Immunohistochemistry; NUT; Spermatocytic seminoma; Testicular neoplasms

Indexed keywords

CANCER TESTIS ANTIGEN; MONOCLONAL ANTIBODY; NUCLEAR PROTEIN IN TESTIS; NY ESO 1 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; CTAG1B PROTEIN, HUMAN; GAGE7 PROTEIN, HUMAN; MEMBRANE PROTEIN; NUCLEAR PROTEIN; NUT PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; EMBRYONAL CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEMINOMA; SENSITIVITY AND SPECIFICITY; SERTOLI CELL; SPERMATID; SPERMATOCYTE; SPERMATOCYTIC SEMINOMA; SPERMATOGONIUM; SPERMATOZOON; YOLK SAC TUMOR; CARCINOMA, EMBRYONAL; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; ENDODERMAL SINUS TUMOR; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

ANTIGENS, NEOPLASM; CARCINOMA, EMBRYONAL; DIAGNOSIS, DIFFERENTIAL; ENDODERMAL SINUS TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASMS, GERM CELL AND EMBRYONAL; NUCLEAR PROTEINS; ONCOGENE PROTEINS; SEMINOMA; SENSITIVITY AND SPECIFICITY; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902072724     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12365     Document Type: Article

References (42)

1. Scully RE. Spermatocytic seminoma of the testis. A report of 3 cases and review of the literature. Cancer 1961; 14; 788-794.
2. Rosai J, Silber I, Khodadoust K. Spermatocytic seminoma. I. Clinicopathologic study of six cases and review of the literature. Cancer 1969; 24; 92-102.
3. Dundr P, Pesl M, Povysil C et al. Anaplastic variant of spermatocytic seminoma. Pathol. Res. Pract. 2007; 203; 621-624.
4. Kao CS, Idrees MT, Young RH, Ulbright TM. Solid pattern yolk sac tumor: a morphologic and immunohistochemical study of 52 cases. Am. J. Surg. Pathol. 2012; 36; 360-367.
5. Albores-Saavedra J, Huffman H, Alvarado-Cabrero I, Ayala AG. Anaplastic variant of spermatocytic seminoma. Hum. Pathol. 1996; 27; 650-655.
6. Lombardi M, Valli M, Brisigotti M, Rosai J. Spermatocytic seminoma: review of the literature and description of a new case of the anaplastic variant. Int. J. Surg. Pathol. 2011; 19; 5-10.
7. Masson P. Etude sur le seminome. Rev. Can. Biol. 1946; 5; 361-387.
8. Eble JN. Spermatocytic seminoma. Hum. Pathol. 1994; 25; 1035-1042.
9. Cummings OW, Ulbright TM, Eble JN, Roth LM. Spermatocytic seminoma: an immunohistochemical study. Hum. Pathol. 1994; 25; 54-59.
10. Kraggerud SM, Berner A, Bryne M, Pettersen EO, Fossa SD. Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. APMIS 1999; 107; 297-302.
11. Stoop H, van Gurp R, de Krijger R et al. Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab. Invest. 2001; 81; 919-928.
12. Decaussin M, Borda A, Bouvier R et al. Spermatocytic seminoma. A clinicopathological and immunohistochemical study of 7 cases. Ann. Pathol. 2004; 24; 161-166.
13. Cao D, Li J, Guo CC, Allan RW, Humphrey PA. Sall4 is a novel diagnostic marker for testicular germ cell tumors. Am. J. Surg. Pathol. 2009; 33; 1065-1077.
14. Haack H, Johnson LA, Fry CJ et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am. J. Surg. Pathol. 2009; 33; 984-991.
15. Satie AP, Rajpert-De Meyts E, Spagnoli GC et al. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab. Invest. 2002; 82; 775-780.
16. Rajpert-De Meyts E, Jacobsen GK, Bartkova J et al. The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 2003; 42; 217-226.
17. Looijenga LH, Hersmus R, Gillis AJ et al. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res. 2006; 66; 290-302.
18. Chen YT, Chiu R, Lee P, Beneck D, Jin B, Old LJ. Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma. Hum. Reprod. 2011; 26; 3232-3243.
19. Lim J, Goriely A, Turner GD et al. OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J. Pathol. 2011; 224; 473-483.
20. Burke A, Mostofi FK. Spermatocytic seminoma: a clinicopathologic study of 79 cases. J. Urol. Pathol. 1993; 1; 21-32.
21. True LD, Otis CN, Delprado W, Scully RE, Rosai J. Spermatocytic seminoma of testis with sarcomatous transformation. A report of five cases. Am. J. Surg. Pathol. 1988; 12; 75-82.
22. Floyd C, Ayala AG, Logothetis CJ, Silva EG. Spermatocytic seminoma with associated sarcoma of the testis. Cancer 1988; 61; 409-414.
23. Matoska J, Talerman A. Spermatocytic seminoma associated with rhabdomyosarcoma. Am. J. Clin. Pathol. 1990; 94; 89-95.
24. Bishop EF, Badve S, Morimiya A, Saxena R, Ulbright TM. Apoptosis in spermatocytic and usual seminomas: a light microscopic and immunohistochemical study. Mod. Pathol. 2007; 20; 1036-1044.
25. Rosai J, Khodadoust K, Silber I. Spermatocytic seminoma. II. Ultrastructural study. Cancer 1969; 24; 103-116.
26. Talerman A. Spermatocytic seminoma. J. Urol. 1974; 112; 212-221.
27. Talerman A. Spermatocytic seminoma: clinicopathological study of 22 cases. Cancer 1980; 45; 2169-2176.
28. Talerman A, Fu YS, Okagaki T. Spermatocytic seminoma. Ultrastructural and microspectrophotometric observations. Lab. Invest. 1984; 51; 343-349.
29. Dekker I, Rozeboom T, Delemarre J, Dam A, Oosterhuis JW. Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma. Cancer 1992; 69; 993-996.
30. Carriere P, Baade P, Fritschi L. Population based incidence and age distribution of spermatocytic seminoma. J. Urol. 2007; 178; 125-128.
31. Leroy X, Augusto D, Leteurtre E, Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J. Histochem. Cytochem. 2002; 50; 283-285.
32. Pollack SM, Jungbluth AA, Hoch BL et al. NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma. Cancer 2012; 118; 4564-4570.
33. Hemminger JA, Ewart Toland A, Scharschmidt TJ et al. The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas. Mod. Pathol. 2013; 26; 282-288.
34. Hemminger JA, Iwenofu OH. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms. Mod. Pathol. 2013; 26; 1204-1210.
35. Montgomery E, Fisher C. Paratesticular liposarcoma: a clinicopathologic study. Am. J. Surg. Pathol. 2003; 27; 40-47.
36. Thanakit V, Nelson SD, Udomsawaengsup S. Round cell liposarcoma of scrotum with indolent course in young adult. J. Med. Assoc. Thai. 2005; 88; 1302-1307.
37. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat. Rev. Cancer 2005; 5; 615-625.
38. Jungbluth AA, Silva WA Jr, Iversen K et al. Expression of cancer-testis (CT) antigens in placenta. Cancer Immun. 2007; 7; 15.
39. Looijenga LH, Stoop H, de Leeuw HP et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003; 63; 2244-2250.
40. Trivedi P, Pasricha S, Gupta A. Spermatocytic seminoma associated with undifferentiated sarcoma: a rare case report. Indian J. Pathol. Microbiol. 2011; 54; 138-140.
41. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am. J. Surg. Pathol. 2004; 28; 935-940.
42. Zynger DL, Dimov ND, Luan C, Teh BT, Yang XJ. Glypican 3: a novel marker in testicular germ cell tumors. Am. J. Surg. Pathol. 2006; 30; 1570-1575.